The varying extent of enrichment of p16Ink4a-positive and -negative tumors in the number of CD8+ and CD4+ cells may be a consequence of diverse expression of tumor associated antigens (TAAs), MHC antigens, costimulatory molecules, and the statuses of antigen-presenting cells (APCs) [16]. The gene discussed is CD8A; the disease is neoplasm.